Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/14/2025

Initial Management of New Pulmonary Emphysema on Chest CT

Confirm the Diagnosis with Spirometry

  • The American Thoracic Society recommends confirming airflow obstruction with spirometry to establish the diagnosis of COPD and guide treatment intensity, measuring FEV1 and FEV1/FVC ratio—an FEV1/FVC <70% with FEV1 <80% predicted confirms airflow obstruction 3
  • Perform bronchodilator reversibility testing: measure spirometry before and 15-30 minutes after nebulized salbutamol (2.5-5 mg) or ipratropium (500 µg) to establish post-bronchodilator FEV1, which predicts long-term prognosis 3

Immediate Risk Factor Reduction

  • The American College of Chest Physicians recommends smoking cessation as the single most important intervention, using a structured five-step intervention combining pharmacotherapy (varenicline, bupropion, or nortriptyline) with behavioral support—this achieves long-term quit rates up to 25% 1
  • Assess and reduce exposure to occupational dusts, fumes, gases, and indoor/outdoor air pollutants, as recommended by the American Thoracic Society 4, 1, 2

Initiate Pharmacologic Therapy Based on Symptoms

  • The GOLD guidelines provide a clear algorithmic approach based on symptom burden and exacerbation history, recommending initiation of LABA/LAMA combination therapy as first-line treatment for patients with exacerbation history (Groups C and D) 4, 5
  • For patients with mild symptoms (Group A), start with either a short- or long-acting bronchodilator based on patient preference, as recommended by the American College of Chest Physicians 4, 5
  • For patients with more breathlessness but few exacerbations (Group B), start with a long-acting bronchodilator (LABA or LAMA), as recommended by the American Thoracic Society 4, 5, 1, 2

Arrange Pulmonary Rehabilitation

  • The American Thoracic Society recommends referring patients with high symptom burden (breathlessness limiting daily activities) to pulmonary rehabilitation immediately, which significantly improves symptoms, quality of life, physical and emotional participation in daily activities, and reduces readmissions and mortality 4, 1, 2

Assess Need for Oxygen Therapy

  • The British Thoracic Society recommends obtaining arterial blood gas measurement if the patient has resting oxygen saturation ≤92% on room air, and prescribing long-term oxygen therapy (>15 hours/day) only if severe resting hypoxemia is confirmed: PaO2 ≤55 mmHg or SaO2 ≤88% on two occasions over 3 weeks while clinically stable 6, 1, 2

Provide Patient Education and Self-Management

  • The American College of Chest Physicians recommends education on smoking cessation strategies, correct inhaler technique, early recognition of exacerbation symptoms, and when to seek medical help, as well as self-management interventions with written action plans to reduce hospitalizations and improve health status 1

Screen for Alpha-1 Antitrypsin Deficiency

  • The American Thoracic Society recommends testing for alpha-1 antitrypsin deficiency if the patient is younger (<45 years), has a family history of early emphysema, or has basilar-predominant emphysema on CT, and considering augmentation therapy for patients with severe hereditary alpha-1 antitrypsin deficiency and established emphysema 4

Arrange Follow-Up and Monitoring

  • The American College of Chest Physicians recommends reassessing symptoms, exacerbation frequency, and spirometry at 3-6 months to guide treatment escalation or de-escalation, and considering palliative care consultation for patients with advanced disease to address dyspnea, anxiety, depression, and advance care planning 4, 1, 2